Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This study will measure the impact of treatment with pregabalin in adult men and women who
have a diagnosis of peripheral neuropathic pain (pain caused by a primary lesion of the
peripheral nervous system such as Diabetic peripheral Neuropathy and Postherpetic Neuralgia).
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.